Metallomics · 2011 · 40 citations · 25 references
PharmacyChemistryMedicinal ChemistryDrug DesignDrug DiscoveryStructural BiologyCoordination ChemistryLigand BindingLigand-based DesignMetal-ligand BondingTransition Metal ComplexesDisaggregationIntermolecular Metal-ligand InteractionsMetal InteractionsMetal Ion Binding To Aggregation-prone ProteinsMetal Ion ChelationMetal-based TherapeuticsMultidimensional Nmr SpectroscopyRational Design
Metal ions associated with amyloid-β (Aβ) species have been suggested to be involved in neurodegeneration leading to the progression of Alzheimer's disease (AD). The role of metal-involved Aβ species in AD neuropathogenesis, however, is not fully elucidated. In order to advance this understanding and contribute to the therapeutic development for AD, the rational structure-based design of small molecules that specifically target metal ions surrounded by Aβ species has recently received increased attention. To date, only a few compounds have been fashioned for this purpose. Herein, we report the design strategy, synthesis, characterization, and reactivity of new bifunctional IMPY derivatives K1 and K2. Using UV-vis and high-resolution two-dimensional (2D) NMR spectroscopy, the bifunctionality of K1 and K2 (metal chelation and Aβ interaction) was confirmed. These bifunctional IMPY derivatives showed preferential reactivity toward metal-induced Aβ aggregation over metal-free conditions in both in vitro inhibition and disaggregation experiments. Taken together, this study provides another example of a bifunctional small molecule framework that can target metal ions associated with Aβ species.
25
Copper, iron and zinc in Alzheimer's disease senile plaques
Mark A. Lovell, J. David Robertson, W.J. Teesdale et al. · Journal of the Neurological Sciences · 1998 · 2.1K citations
Lucia Alderighi, Peter Gans, Andrea Ienco et al. · Coordination Chemistry Reviews · 1999 · 1.6K citations